Regeneron Pharmaceuticals Inc. buy kostojunior
Start price
10.07.22
/
80%
€613.40
Target price
10.07.23
€999.00
Performance (%)
-6.06%
End price
23.07.22
€576.20
Summary
This prediction ended on 23.07.22 with a price of €576.20. With a performance of -6.06%, the BUY prediction by kostojunior finished with a loss. kostojunior has 80% into this predictionRegeneron Pharmaceuticals, Inc. is a biotechnology company that is engaged in the discovery, development, and commercialization of medicines for the treatment of serious medical conditions. The company's products include EYLEA, a treatment for wet age-related macular degeneration and diabetic macular edema; Dupixent, a treatment for atopic dermatitis and asthma; and Libtayo, a treatment for certain types of cancer. Regeneron also has a strong focus on research and development, with a pipeline of potential new treatments for a variety of diseases. The company is headquartered in Tarrytown, New York and trades on the NASDAQ stock exchange under the symbol REGN.
Performance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Regeneron Pharmaceuticals Inc. | 8.074% | 8.074% | 30.470% |
| iShares Core DAX® | 2.831% | 1.236% | 14.788% |
| iShares Nasdaq 100 | 2.918% | 0.640% | 40.290% |
| iShares Nikkei 225® | 2.007% | -2.135% | 19.861% |
| iShares S&P 500 | 2.257% | 0.451% | 30.090% |
According to kostojunior what are the pros and cons of Regeneron Pharmaceuticals Inc. for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Cons
Comments by kostojunior for this prediction
In the thread Regeneron Pharmaceuticals Inc. diskutieren
Buy mit Kursziel 999,0
In the thread Trading Regeneron Pharmaceuticals Inc.
Einschätzung wurde nach dem Ende von Catch the Monkey automatisch beendet.